CTNI-48. NERATINIB FOR NF2 -RELATED SCHWANNOMATOSIS WITH PROGRESSIVE TUMORS: INTERIM ANALYSIS FROM THE INTUITT-NF2 PLATFORM-BASKET TRIAL

Journal article

Peer reviewed

Scott Plotkin, Phioanh Nghiemphu, Kaleb Yohay, Christine Dinh, Vanessa Merker, Geoffrey Fell, Lorenzo Trippa and Jaishri Blakeley

Neuro-oncology (Charlottesville, Va.), Vol.27(Supplement_5), pp.v137-v137

2025-11-11

Metrics

1 Record Views

Title: CTNI-48. NERATINIB FOR NF2 -RELATED SCHWANNOMATOSIS WITH PROGRESSIVE TUMORS: INTERIM ANALYSIS FROM THE INTUITT-NF2 PLATFORM-BASKET TRIAL
Creators: Scott Plotkin - Massachusetts General Hospital
Phioanh Nghiemphu - University of California, Los Angeles
Kaleb Yohay - New York University
Christine Dinh - University of Miami
Vanessa Merker - Massachusetts General Hospital
Geoffrey Fell - Dana-Farber Cancer Institute
Lorenzo Trippa - Dana-Farber Cancer Institute
Jaishri Blakeley - Johns Hopkins University
Publication Details: Neuro-oncology (Charlottesville, Va.), Vol.27(Supplement_5), pp.v137-v137
Publisher: OXFORD UNIV PRESS INC; CARY
Number of pages: 1
Academic Unit: UMMG Department of Otolaryngology; Miller School of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991032859336502976